September 22, 2021
Article
Patients with cancer now have official confirmation that vaccinating against COVID-19 will protect them from contracting the virus.
September 21, 2021
Video
With the Delta cases surging in recent weeks, and the upcoming flu season almost upon us, here is a glimpse of what providers and the public can expect when both viruses are circulating.
After two doses of the Pfizer-BioNTech COVID-19 vaccine, 83% of allogeneic hematopoietic stem cell transplant recipients showed positive antibody response.
Preprint data from a real-world evidence assessment, as well as preliminary reports from a 2-dose trial, support the company's pursuit for FDA authorization of a second COVID-19 vaccine dose.
September 20, 2021
The regulatory setback is regarding a manufacturing facility concern not associated with the investigative drug, according to the company.
Antiretroviral therapy for HIV offers a protective outcome against preterm birth for pregnant women with HIV.
The data, which reflects pre-pandemic routine vaccination levels, showed human papillomavirus vaccine rates increased among teens ages 13-17.
A smaller dosage was used and with their results the two companies plan to submit their data to governmental regulatory agencies around the world.
September 18, 2021
The Centers for Disease Control and Prevention's (CDC) VISION Network of health care systems provided data for test-negative design analysis of vaccine effectiveness in preventing COVID-19 acute admissions.
September 17, 2021
After voting against recommendation of a booster dose for people 16 years and older, the committee created a new question to vote on an EUA for a booster dose for people 65 years and older and those at high risk of COVID-19. They voted 18-0 in favor.
